Dean of the Faculty of Pharmacy, Université de Lorraine, France
Prof. Raphaël E. Duval is a distinguished microbiologist, virologist, and pharmaceutical researcher, currently serving as the Dean of the Faculty of Pharmacy at Université de Lorraine. With a career spanning over two decades, he has made significant contributions to the development of novel anti-infective and anticancer agents. His research has been widely recognized, earning him prestigious grants and awards. Prof. Duval has authored 87 international publications, 7 book chapters, and 15 proceedings, demonstrating his leadership in clinical microbiology and pharmaceutical sciences. His expertise extends to nanotechnology-based drug development, antimicrobial resistance, and cancer therapies. A dedicated academic, he has mentored numerous researchers while maintaining an active role in global scientific communities. He is a member of the American Society for Microbiology and the French Society for Microbiology. His pioneering work continues to impact pharmaceutical sciences, shaping future treatments for infectious diseases and cancer.
Profile
Education 🎓
Prof. Duval holds multiple advanced degrees in microbiology, virology, and pharmaceutical sciences. He earned his PharmD in Microbiology (2018) from Université de Lorraine and his HDR (Habilitation) in Infectiology (2010) from Nancy-University, establishing his expertise in infectious diseases. He obtained his PhD in Virology, Cellular Biology & Biochemistry (2003) from the University of Limoges, where he conducted research on viral mechanisms and drug resistance. His MSc in Cellular Biology, Structural Biology & Microbiology (1997) from the University of Luminy, Marseille, provided a solid foundation in molecular and structural biology. Throughout his academic journey, he has combined interdisciplinary knowledge to develop innovative antimicrobial and anticancer strategies. His educational background reflects a strong commitment to advancing pharmaceutical sciences and tackling critical global health challenges.
Experience 🏛️
Prof. Duval has had an illustrious academic and research career, beginning as an Assistant Professor in Microbiology (2004-2010) at Nancy-University before being promoted to Associate Professor (2010-2012). Since 2012, he has been a Full Professor in Clinical Microbiology at Université de Lorraine, leading groundbreaking research in infectious diseases and pharmaceutical sciences. His postdoctoral training includes positions at the University of Limoges (2001-2003) and the University of Caen Basse-Normandie (2004). His leadership extends beyond academia, as he currently serves as the Dean of the Faculty of Pharmacy at Nancy, overseeing strategic research initiatives and academic programs. Prof. Duval’s expertise in clinical microbiology, nanomedicine, and pharmaceutical innovation has positioned him as a leading figure in drug discovery and antimicrobial resistance studies, impacting both academia and the pharmaceutical industry.
Honors & Awards 🏆
Prof. Duval’s research excellence has been recognized through multiple prestigious international awards and grants:
✅ ICAAC Infectious Disease Fellows Grant Program – Boston (2010), Denver (2013)
✅ George McCracken Infectious Disease Fellows Grant – Chicago (2011), San Diego (2015)
✅ ASM Infectious Disease Fellow Travel Grant – San Francisco (2012)
✅ Grand Prix de La Recherche, Prix aux Laboratoires Universitaires – Société Industrielle de l’Est, Nancy (2012)
✅ Luoja Lecture on Pharmacy Laureate – Wuhan University (2019)
His continuous recognition highlights his pioneering contributions to microbiology, infectious diseases, and pharmaceutical innovation.
Research Focus 🔬
Prof. Duval’s research centers on the development of novel anti-infective and anticancer agents. His work spans nanotechnology-based drug delivery systems, antimicrobial resistance, and innovative cancer therapeutics. His key focus areas include:
🦠 New Antibacterial & Antiviral Compounds – Targeting multi-drug-resistant pathogens
💊 Anticancer Drug Development – Investigating natural and synthetic molecules for cancer treatment
🧬 Nanomedicine & Drug Delivery – Using nanoparticles to enhance drug efficacy
🔬 Molecular Pharmacology & Virology – Understanding virus-host interactions
His groundbreaking work continues to shape the future of infectious disease treatment and cancer therapy.
Publications 📚
📖Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy – Pharmaceutics, 2025
📖 Ursolic Acid’s Alluring Journey: One Triterpenoid vs. Cancer Hallmarks – Molecules, 2023
📖 Sedimentation Field-Flow Fractionation: A Diagnostic Tool for Rapid Antimicrobial Susceptibility Testing – Analytical Chemistry, 2023
📖 The Promise of Piperine in Cancer Chemoprevention – Cancers, 2023
📖 Inorganic Nanoparticles: Tools to Emphasize the Janus Face of Amphotericin B – Antibiotics, 2023
📖 Functionalized Calixarenes as Promising Antibacterial Drugs to Face Antimicrobial Resistance – Molecules, 2023
📖 Design, Semi-Synthesis and Molecular Docking of New Antibacterial and Antibiofilm Triazole Conjugates from Hydroxy-Triterpene Acids and Fluoroquinolones – New Journal of Chemistry, 2023
📖 Photothermal/Photoacoustic Therapy Combined with Metal-Based Nanomaterials for the Treatment of Microbial Infections – Microorganisms, 2023
📖 Polyphenol-Based Nanoparticles: A Promising Frontier for Enhanced Colorectal Cancer Treatment – Cancers, 2023